Effects of group exposure on single injection-induced behavioral sensitization to drugs of abuse in mice.
Roberta Procópio-Souza, Daniela F Fukushiro, Thaís F Trombin, Raphael Wuo‐silva, Lineane H F Zanlorenci, Alexandre J O Lima, Luciana T C Ribeiro, Jussara M R M Corrêa, Eduardo A V Marinho, Sonia R Kameda, Mônica L. Andersen, Sergio Tufik, Roberto Frussa‐filho
Drug and Alcohol Dependence November 1, 2011 DOI: 10.1016/j.drugalcdep.2011.04.017 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental animal study Peer reviewed |
|---|---|
| Population | C57BL/6 mice |
| Interventions | MDMA d-amphetamine morphine ethanol |
| Duration | Priming session followed by challenge session seven days later |
| Key findings | Group exposure during drug administration potentiated MDMA-induced hyperlocomotion and locomotor sensitization, attenuated morphine sensitization, and left d-amphetamine sensitization unchanged, while no sensitization developed to the social-interaction effects of MDMA, morphine, or ethanol. The authors argue these results provide preclinical evidence that neuronal adaptations related to drug dependence can be specifically influenced by social context. |
Abstract
Behavioral sensitization in rodents is hypothesized to reflect neuronal adaptations that are related to drug addiction in humans. We evaluated the effects of group exposure on the acute hyperlocomotion and behavioral sensitization induced by four drugs of abuse in C57BL/6 mice: methylenedioxymethamphetamine (MDMA), d-amphetamine, morphine and ethanol. In the priming session, animals received an ip injection of one of the drugs of abuse and were exposed to an open field either individually or in groups of four. Seven days later, we assessed behavioral sensitization in the challenge session. All animals received an ip injection of the same drug and were exposed to the open field in the same social conditions described for the priming session. Locomotion and social interaction were quantified during each session. Acute MDMA, morphine and ethanol, but not d-amphetamine, increased social interaction. However, group exposure only potentiated MDMA-induced hyperlocomotion. After a challenge injection of each drug, there was no sensitization to the facilitating effect of MDMA, morphine or ethanol on social interaction, but locomotion sensitization developed to all drugs of abuse except ethanol. This sensitization was potentiated by group exposure in MDMA-treated animals, attenuated in morphine-treated animals and not modified in d-amphetamine-treated animals. Acute MDMA enhanced body contact and peaceful following, while acute morphine and ethanol increased social sniffing. These results provide preclinical evidence showing that while different drugs of abuse affect different components of social interaction, the neuronal adaptations related to drug dependence can be critically and specifically influenced by group exposure.
Citations in the library
Cited by 4
- The Prosocial Effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled Studies in Humans and Laboratory Animals Neuroscience & Biobehavioral Reviews September 25, 2015
- A Systematic Review of the MDMA Model to Address Social Impairment in Autism. Current Neuropharmacology 2021
- Of mice and men on MDMA: a translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine ('Ecstasy'). Brain Research November 14, 2019
- (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA. Psychopharmacology February 2018
Cites 6
- Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug British Journal of Addiction August 1, 1992
- Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice PLoS One November 20, 2009
- Neural correlates of MDMA (“Ecstasy”)-induced social interaction in rats Social Neuroscience June 21, 2008
- History of MDMA Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA 1990
- The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacological Reviews September 2003
and 1 more in the library